| Balance Sheets | 2025-06-30 | |||
|---|---|---|---|---|
| Intangible assets, net | 110,234 | |||
| Accounts receivable | 36,676 | |||
| Prepaid expenses | 154,864 | |||
| Inventory | 105,688 | |||
| Cash and cash equivalents | 1,614,254 | |||
| Total current assets | 1,911,482 | |||
| Property and equipment, net | 504,409 | |||
| Other assets | 7,264 | |||
| Right of use asset, net | 273,461 | |||
| Goodwill | 1,679,978 | |||
| Total assets | 4,486,828 | |||
| Derivative liability | 6,166 | |||
| Notes payable-related parties-Related Party | 7,800 | |||
| Lease liability, current portion | 64,176 | |||
| Notes payable, net | 17,722,932 | |||
| Convertible notes payable, net | 43,138 | |||
| Customer advances | 121,770 | |||
| Accrued interest | 12,396,257 | |||
| Accounts payable and accrued liabilities | 179,538 | |||
| Total current liabilities | 30,541,777 | |||
| Lease liability, net of current portion | 209,285 | |||
| Notes payable, net of current portion | 2,757,016 | |||
| Total liabilities | 33,508,078 | |||
| Accumulated deficit | -69,618,927 | |||
| Preferred stock, value-Series DPreferred Stock | 10 | |||
| Preferred stock, value-Series CPreferred Stock | 1 | |||
| Preferred stock, value-Series APreferred Stock | 1,050 | |||
| Common stock, 0.001 par value 100,000,000 shares authorized 12,538,968 issued and outstanding as of june 30, 2025, and december 31, 2024, respectively | 12,539 | |||
| Additional paid in capital | 40,584,077 | |||
| Total stockholders deficit | -29,021,250 | |||
| Total liabilities and stockholders deficit | 4,486,828 | |||
Regenerative Medical Technology Group Inc. (RMTG)
Regenerative Medical Technology Group Inc. (RMTG)